The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Vaccination Market Research Report 2025
Synopsis
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
The global Tuberculosis Vaccination market was valued at US$ 76 million in 2023 and is anticipated to reach US$ 93 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccination.
Report Scope
The Tuberculosis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
The global Tuberculosis Vaccination market was valued at US$ 76 million in 2023 and is anticipated to reach US$ 93 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccination.
Report Scope
The Tuberculosis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tuberculosis Vaccination Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccination
1.2 Tuberculosis Vaccination Segment by Type
1.2.1 Global Tuberculosis Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Vaccination Segment by Application
1.3.1 Global Tuberculosis Vaccination Market Value by Application: (2024-2030)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Vaccination Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Vaccination Revenue 2019-2030
1.4.2 Global Tuberculosis Vaccination Sales 2019-2030
1.4.3 Global Tuberculosis Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tuberculosis Vaccination Market Competition by Manufacturers
2.1 Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tuberculosis Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tuberculosis Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Tuberculosis Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Vaccination, Product Type & Application
2.7 Tuberculosis Vaccination Market Competitive Situation and Trends
2.7.1 Tuberculosis Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccination Players Market Share by Revenue
2.7.3 Global Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccination Retrospective Market Scenario by Region
3.1 Global Tuberculosis Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tuberculosis Vaccination Global Tuberculosis Vaccination Sales by Region: 2019-2030
3.2.1 Global Tuberculosis Vaccination Sales by Region: 2019-2024
3.2.2 Global Tuberculosis Vaccination Sales by Region: 2025-2030
3.3 Global Tuberculosis Vaccination Global Tuberculosis Vaccination Revenue by Region: 2019-2030
3.3.1 Global Tuberculosis Vaccination Revenue by Region: 2019-2024
3.3.2 Global Tuberculosis Vaccination Revenue by Region: 2025-2030
3.4 North America Tuberculosis Vaccination Market Facts & Figures by Country
3.4.1 North America Tuberculosis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tuberculosis Vaccination Sales by Country (2019-2030)
3.4.3 North America Tuberculosis Vaccination Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tuberculosis Vaccination Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tuberculosis Vaccination Sales by Country (2019-2030)
3.5.3 Europe Tuberculosis Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tuberculosis Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Tuberculosis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tuberculosis Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Tuberculosis Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tuberculosis Vaccination Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tuberculosis Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Tuberculosis Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tuberculosis Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tuberculosis Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tuberculosis Vaccination Sales by Type (2019-2030)
4.1.1 Global Tuberculosis Vaccination Sales by Type (2019-2024)
4.1.2 Global Tuberculosis Vaccination Sales by Type (2025-2030)
4.1.3 Global Tuberculosis Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Tuberculosis Vaccination Revenue by Type (2019-2030)
4.2.1 Global Tuberculosis Vaccination Revenue by Type (2019-2024)
4.2.2 Global Tuberculosis Vaccination Revenue by Type (2025-2030)
4.2.3 Global Tuberculosis Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Tuberculosis Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tuberculosis Vaccination Sales by Application (2019-2030)
5.1.1 Global Tuberculosis Vaccination Sales by Application (2019-2024)
5.1.2 Global Tuberculosis Vaccination Sales by Application (2025-2030)
5.1.3 Global Tuberculosis Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Tuberculosis Vaccination Revenue by Application (2019-2030)
5.2.1 Global Tuberculosis Vaccination Revenue by Application (2019-2024)
5.2.2 Global Tuberculosis Vaccination Revenue by Application (2025-2030)
5.2.3 Global Tuberculosis Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Tuberculosis Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Tuberculosis Vaccination Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Japan BCG Lab Tuberculosis Vaccination Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute of India Tuberculosis Vaccination Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AJ Vaccines Tuberculosis Vaccination Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioFarma Tuberculosis Vaccination Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Tuberculosis Vaccination Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biomed Lublin Tuberculosis Vaccination Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Corporation Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ataulpho de Paiva Tuberculosis Vaccination Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC – Institute of Vaccines and Medical Biologicals
6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Corporation Information
6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Description and Business Overview
6.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.11.4 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Portfolio
6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Corporation Information
6.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccination Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Corporation Information
6.13.2 Microgen Tuberculosis Vaccination Description and Business Overview
6.13.3 Microgen Tuberculosis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Microgen Tuberculosis Vaccination Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Vaccination Industry Chain Analysis
7.2 Tuberculosis Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Vaccination Production Mode & Process
7.4 Tuberculosis Vaccination Sales and Marketing
7.4.1 Tuberculosis Vaccination Sales Channels
7.4.2 Tuberculosis Vaccination Distributors
7.5 Tuberculosis Vaccination Customers
8 Tuberculosis Vaccination Market Dynamics
8.1 Tuberculosis Vaccination Industry Trends
8.2 Tuberculosis Vaccination Market Drivers
8.3 Tuberculosis Vaccination Market Challenges
8.4 Tuberculosis Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tuberculosis Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tuberculosis Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tuberculosis Vaccination Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tuberculosis Vaccination Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Vaccination Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Vaccination Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tuberculosis Vaccination Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tuberculosis Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccination as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tuberculosis Vaccination Sales by Region (2019-2024) & (K Units)
Table 18. Global Tuberculosis Vaccination Sales Market Share by Region (2019-2024)
Table 19. Global Tuberculosis Vaccination Sales by Region (2025-2030) & (K Units)
Table 20. Global Tuberculosis Vaccination Sales Market Share by Region (2025-2030)
Table 21. Global Tuberculosis Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tuberculosis Vaccination Revenue Market Share by Region (2019-2024)
Table 23. Global Tuberculosis Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tuberculosis Vaccination Revenue Market Share by Region (2025-2030)
Table 25. North America Tuberculosis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tuberculosis Vaccination Sales by Country (2019-2024) & (K Units)
Table 27. North America Tuberculosis Vaccination Sales by Country (2025-2030) & (K Units)
Table 28. North America Tuberculosis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tuberculosis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tuberculosis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tuberculosis Vaccination Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tuberculosis Vaccination Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tuberculosis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tuberculosis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Vaccination Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tuberculosis Vaccination Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tuberculosis Vaccination Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tuberculosis Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tuberculosis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tuberculosis Vaccination Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tuberculosis Vaccination Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tuberculosis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tuberculosis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tuberculosis Vaccination Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tuberculosis Vaccination Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tuberculosis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tuberculosis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tuberculosis Vaccination Sales (K Units) by Type (2019-2024)
Table 51. Global Tuberculosis Vaccination Sales (K Units) by Type (2025-2030)
Table 52. Global Tuberculosis Vaccination Sales Market Share by Type (2019-2024)
Table 53. Global Tuberculosis Vaccination Sales Market Share by Type (2025-2030)
Table 54. Global Tuberculosis Vaccination Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tuberculosis Vaccination Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tuberculosis Vaccination Revenue Market Share by Type (2019-2024)
Table 57. Global Tuberculosis Vaccination Revenue Market Share by Type (2025-2030)
Table 58. Global Tuberculosis Vaccination Price (US$/Unit) by Type (2019-2024)
Table 59. Global Tuberculosis Vaccination Price (US$/Unit) by Type (2025-2030)
Table 60. Global Tuberculosis Vaccination Sales (K Units) by Application (2019-2024)
Table 61. Global Tuberculosis Vaccination Sales (K Units) by Application (2025-2030)
Table 62. Global Tuberculosis Vaccination Sales Market Share by Application (2019-2024)
Table 63. Global Tuberculosis Vaccination Sales Market Share by Application (2025-2030)
Table 64. Global Tuberculosis Vaccination Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tuberculosis Vaccination Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tuberculosis Vaccination Revenue Market Share by Application (2019-2024)
Table 67. Global Tuberculosis Vaccination Revenue Market Share by Application (2025-2030)
Table 68. Global Tuberculosis Vaccination Price (US$/Unit) by Application (2019-2024)
Table 69. Global Tuberculosis Vaccination Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Tuberculosis Vaccination Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Corporation Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Japan BCG Lab Tuberculosis Vaccination Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Serum Institute of India Tuberculosis Vaccination Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Corporation Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AJ Vaccines Tuberculosis Vaccination Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Corporation Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioFarma Tuberculosis Vaccination Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Corporation Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GreenSignal Bio Pharma Tuberculosis Vaccination Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Corporation Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. China National Biotec Tuberculosis Vaccination Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Corporation Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biomed Lublin Tuberculosis Vaccination Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Taj Pharmaceuticals Tuberculosis Vaccination Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Corporation Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ataulpho de Paiva Tuberculosis Vaccination Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. IVAC – Institute of Vaccines and Medical Biologicals Corporation Information
Table 121. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
Table 122. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product
Table 124. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
Table 125. Queen Saovabha Mem. Inst Corporation Information
Table 126. Queen Saovabha Mem. Inst Description and Business Overview
Table 127. Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Queen Saovabha Mem. Inst Tuberculosis Vaccination Product
Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 130. Microgen Corporation Information
Table 131. Microgen Description and Business Overview
Table 132. Microgen Tuberculosis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Microgen Tuberculosis Vaccination Product
Table 134. Microgen Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Tuberculosis Vaccination Distributors List
Table 138. Tuberculosis Vaccination Customers List
Table 139. Tuberculosis Vaccination Market Trends
Table 140. Tuberculosis Vaccination Market Drivers
Table 141. Tuberculosis Vaccination Market Challenges
Table 142. Tuberculosis Vaccination Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Vaccination
Figure 2. Global Tuberculosis Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tuberculosis Vaccination Market Share by Type in 2023 & 2030
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Tuberculosis Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tuberculosis Vaccination Market Share by Application in 2023 & 2030
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global Tuberculosis Vaccination Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tuberculosis Vaccination Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tuberculosis Vaccination Sales (2019-2030) & (K Units)
Figure 14. Global Tuberculosis Vaccination Average Price (US$/Unit) & (2019-2030)
Figure 15. Tuberculosis Vaccination Report Years Considered
Figure 16. Tuberculosis Vaccination Sales Share by Manufacturers in 2023
Figure 17. Global Tuberculosis Vaccination Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Tuberculosis Vaccination Players: Market Share by Revenue in 2023
Figure 19. Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Tuberculosis Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tuberculosis Vaccination Sales Market Share by Country (2019-2030)
Figure 22. North America Tuberculosis Vaccination Revenue Market Share by Country (2019-2030)
Figure 23. United States Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tuberculosis Vaccination Sales Market Share by Country (2019-2030)
Figure 26. Europe Tuberculosis Vaccination Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tuberculosis Vaccination Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tuberculosis Vaccination Revenue Market Share by Region (2019-2030)
Figure 34. China Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Tuberculosis Vaccination Sales Market Share by Country (2019-2030)
Figure 44. Latin America Tuberculosis Vaccination Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Tuberculosis Vaccination Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Tuberculosis Vaccination Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Tuberculosis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Tuberculosis Vaccination by Type (2019-2030)
Figure 54. Global Revenue Market Share of Tuberculosis Vaccination by Type (2019-2030)
Figure 55. Global Tuberculosis Vaccination Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Tuberculosis Vaccination by Application (2019-2030)
Figure 57. Global Revenue Market Share of Tuberculosis Vaccination by Application (2019-2030)
Figure 58. Global Tuberculosis Vaccination Price (US$/Unit) by Application (2019-2030)
Figure 59. Tuberculosis Vaccination Value Chain
Figure 60. Tuberculosis Vaccination Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
